Georgia State Signs Licensing Agreement With DaZen Theranostics Inc.
Georgia State Signs Licensing Agreement With DaZen Theranostics Inc.
Georgia State University has signed a licensing agreement with DaZen Theranostics Inc., a Delaware-based start-up company, to develop a product that can target cancer cells, function as a contrast agent to improve the visibility of cancer cells during diagnostic imaging and deliver a therapeutic drug to destroy cancerous cells.










